Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2022-05-05Clinical Trial Update: A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer [Phase 3]
Phase III study evaluating HLX10 plus chemotherapy for advanced cervical cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Promoting Cervical Cancer Screening Through the Advocacy of Screened Women [Phase 2]
Phase 2 clinical trial update focusing on promoting cervical cancer screening through advocacy by screened women.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer [Phase 2]
Phase 2 BrUOG 355 trial evaluating nivolumab with tailored radiation therapy and concurrent cisplatin in cervical cancer was terminated; res…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies [Phase 2]
Phase 2 clinical trial evaluating ScTILs (genetically modified tumor infiltrating lymphocytes) for cervical and ovarian cancers (and maligna…
-
FDA approval · 2022-04-13FDA Approved: ALYMSYS — Original Application (Amneal Pharmaceuticals LLC)
FDA approves ALYMSYS as a biosimilar to bevacizumab (bevaczizumab-maly) from Amneal Pharmaceuticals LLC under an original Biologics License …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer [Phase 2]
Phase 2 trial update evaluating PD-1 antibody with chemoradiotherapy for locally advanced cervical cancer (IB2-IIIB).
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers [Phase 1, Phase 2]
A Phase 1/2 trial update reports completed results for combining topotecan with the ATR inhibitor berzosertib (VX-970/M6620) in small cell c…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Tislelizumab and Radiotherapy for Recurrent Cervical Cancer [Phase 2]
A phase 2 clinical trial evaluating tislelizumab in combination with radiotherapy for recurrent/metastatic cervical cancer; current status a…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants [Phase 2]
Phase 2 trial update on the recombinant human papillomavirus nonavalent vaccine for preventing HPV infection in younger healthy participants…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Donafenib for Recurrent Cervical Cancer [Phase 2]
Phase 2 clinical trial update for donafenib in recurrent cervical cancer (includes various cervical cancer states and outcome considerations…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive [Phase 1, Phase 2]
Phase 1/2 trial update on a T cell receptor therapy targeting MAGE-A3 in HLA-DP0401 positive metastatic cancer; study completed with posted …
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma [Phase 2]
Phase 2 trial update investigating Compound Kushen Injection combined with Pabolizumab for cervical cancer (cervical adenocarcinoma).
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy [Phase 2]
Phase 2 trial update evaluating immunotherapy for recurrent or persistent advanced cervical carcinoma refractory to platinum-based chemother…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: First-line Chemotherapy for Recurrent Cervical Cancer [Phase 2]
Phase 2 trial update for first-line chemotherapy in recurrent/persistent advanced cervical cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer [Phase 2]
Phase 2 clinical trial evaluating bupropion hydrochloride to improve sexual desire in women with breast or gynecologic cancers has completed…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer [Phase 3]
A Phase 3 randomized study evaluating Z-100 in combination with radiation therapy for cervical cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Image-Guided Gynecologic Brachytherapy [Phase 2]
Phase 2 clinical trial update for image-guided gynecologic brachytherapy in cervical and uterine cancers.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: M7824 in Subjects With HPV Associated Malignancies [Phase 2]
Phase 2 trial update for M7824 in HPV-associated malignancies completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]
Phase 3 trial assessing immunogenicity and safety of 4-valent and 9-valent HPV recombinant vaccine in Chinese healthy females; study complet…
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer [Phase 3]
Phase 3 trial comparing pelvic radiotherapy to prophylactic extended-field radiotherapy in cervical cancer is reported as an update.
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study [NA]
Completed clinical trial evaluating an MRI brachytherapy applicator for cervical cancer with posted results.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: H101 Combined With Camrelizumab for Recurrent Cervical Cancer [Phase 2]
A Phase 2 clinical trial evaluating H101 in combination with camrelizumab for recurrent cervical cancer is reported as ongoing with status u…
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer [Phase 3]
Phase 3 clinical trial evaluating para-aortic prophylactic irradiation for locally advanced cervical cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin [Phase 2, Phase 3]
Phase 2/3 trial update evaluating safety and antiemetic efficacy of Akynzeo with dexamethasone during radiotherapy plus weekly cisplatin in …
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: A Study of Carilizumab Combined With Concurrent Chemoradiotherapy [Phase 2]
Phase 2 trial of Carilizumab with concurrent chemoradiotherapy for cervical cancer is underway with no status information available.